GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 310 participants.

Also called NCT06578741

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 310 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06578741
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT06578741. Allocation not applicable; no masking; primary purpose treatment. Start 2024-11-25 (actual); primary completion 2027-06-25 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study
Condition
Abdominal Aortic Aneurysm
Condition
Pararenal Aortic Aneurysm
Condition
Thoracoabdominal Aortic Aneurysm
Intervention (Device)
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct06578741
Content hash
547db46cbdd5438a722fd4f04dbcda2e3c9be10d85bcac72529c462cace88795